Search

everythinglearnresearchcommunity

for

Search:↓

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Deucravacitinib helped a man regrow hair significantly.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

The FDA approved a new Pfizer drug for hair loss in teens.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Upadacitinib may effectively treat resistant lichen planopilaris.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

A skin rash after the AstraZeneca COVID-19 vaccine was treated successfully with medication.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

A woman with lupus developed rare skin growths that went away on their own.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Mesenchymal stem cells and their secretome may offer a safe and effective treatment for systemic lupus erythematosus.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Higher monocyte counts predict less effective adalimumab treatment in hidradenitis suppurativa patients.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.